Olema Pharmaceuticals Inc (OLMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -129,474 | -96,655 | -104,787 | -71,096 | -22,121 |
| Depreciation Amortization | 393 | 377 | 357 | 439 | 11 |
| Accounts payable and accrued liabilities | 2,510 | 2,324 | 351 | -683 | -220 |
| Other Working Capital | 9,164 | -589 | 3,022 | 2,830 | -1,505 |
| Other Operating Activity | 13,056 | 10,816 | 18,992 | 17,820 | 3,969 |
| Operating Cash Flow | $-104,351 | $-83,727 | $-82,065 | $-50,690 | $-19,866 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -159 | 14 | -363 | -1,575 | -56 |
| Purchase Of Investment | -394,959 | -255,625 | -213,660 | -486,967 | 0 |
| Sale Of Investment | 301,592 | 250,760 | 305,502 | 213,104 | 0 |
| Investing Cash Flow | $-93,526 | $-4,851 | $91,479 | $-275,438 | $-56 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 3,088 |
| Common Stock Issued | 268,818 | 133,415 | 476 | 1,391 | 221,191 |
| Other Financing Activity | 0 | 0 | 0 | 0 | 134,124 |
| Financing Cash Flow | $268,818 | $133,415 | $476 | $1,391 | $358,403 |
| Beginning Cash Position | 68,539 | 23,702 | 13,812 | 338,549 | 68 |
| End Cash Position | 139,480 | 68,539 | 23,702 | 13,812 | 338,549 |
| Net Cash Flow | $70,941 | $44,837 | $9,890 | $-324,737 | $338,481 |
| Free Cash Flow | |||||
| Operating Cash Flow | -104,351 | -83,727 | -82,065 | -50,690 | -19,866 |
| Capital Expenditure | -159 | N/A | -363 | -1,575 | -56 |
| Free Cash Flow | -104,510 | -83,727 | -82,428 | -52,265 | -19,922 |